HI
ZBIO icon

Harbour Investments’s Zenas BioPharma ZBIO Stock Holding History

Harbour Investments’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.39K Sell
370
-1,000
-73% -$19.9K ﹤0.01% 3393
2026
Q1 		$26.8K Buy
+1,370
New +$30.8K ﹤0.01% 2701

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Harbour Investments's ZBIO Position: Q2 2026 in Review

Harbour Investments reduced its Zenas BioPharma (ZBIO) stake by 73% in Q2 2026, selling an estimated $19.9K and leaving 370 shares worth $9.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Harbour Investments first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $26.8K in Q1 2026. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Harbour Investments held 370 shares of Zenas BioPharma worth $9.39K as of Q2 2026.
  • Harbour Investments sold 1,000 Zenas BioPharma shares in Q2 2026, an estimated $19.9K.
  • Zenas BioPharma made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3393 holding.
  • Harbour Investments first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
  • Harbour Investments's Zenas BioPharma position peaked at $26.8K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.